London
9 °C
Manchester
10 °C
Glasgow
Dublin
Belfast
7 °C
Washington
Denver
Atlanta
Dallas
Houston Texas
30 °C
New Orleans
El Paso
Phoenix
22 °C
Los Angeles
15 °C
20 °C
27 °C
-7 °C
18 °C
Aehr Test Systems Reports Record First Quarter Fiscal 2027 Revenue of $33.0 Million; Raises Full-Year Revenue Outlook to $150 Million, Triple Fiscal 2026 Revenue
Aehr Test Systems Reports Record First Quarter Fiscal 2027 Revenue of $33.0 Million; Raises Full-Year Revenue Outlook to $150 Million, Triple Fiscal 2026 Revenue
Strong Quarterly Bookings of $46.7 Million; Effective Backlog Reaches $109.3 Million
FREMONT, CA / ACCESS Newswire / November 2, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced financial results for its first quarter of fiscal 2027 ended September 25, 2026.
Fiscal First Quarter Financial Results:
- Record revenue was $33.0 million, up 200% from $11.0 million in the first quarter of fiscal 2026 and 75% sequentially.
- GAAP gross margin was 47.5%, and non-GAAP gross margin was 48.5%.
- GAAP net income was $7.2 million, or $0.21 per diluted share, compared with a GAAP net loss of $(2.1) million, or $(0.07) per diluted share, in the first quarter of fiscal 2026.
- Non-GAAP net income, which excludes stock-based compensation and acquisition-related adjustments, was $9.4 million, or $0.28 per diluted share, compared with non-GAAP net income of $0.2 million, or $0.01 per diluted share, in the first quarter of fiscal 2026. Non-GAAP net income increased approximately 163% sequentially.
- Bookings were $46.7 million, representing a book-to-bill ratio of approximately 1.4.
- Backlog was $100.9 million as of September 25, 2026. Effective backlog, including bookings received after quarter end, was $109.3 million as of November 1, 2026.
- Cash, cash equivalents and restricted cash totaled $105.1 million as of September 25, 2026, compared to $116.5 million as of May 29, 2026.
An explanation of the use of non-GAAP financial measures and a reconciliation to the most directly comparable GAAP financial measures are included in the accompanying financial tables.
Gayn Erickson, President and CEO of Aehr Test Systems, commented:
"Our fiscal first quarter results demonstrate the accelerating demand for our AI semiconductor test and burn-in solutions and our ability to execute against expanding customer production requirements. Revenue increased 200% year over year and 75% sequentially to a record $33.0 million, while bookings of $46.7 million exceeded revenue by over 40%, reflecting continued strong demand for our wafer-level and package-level burn-in solutions.
"Based on our first quarter performance, substantial backlog, and visibility into customer production requirements, we are raising our fiscal 2027 revenue outlook to $150 million, compared with our previous guidance range of $130 million to $150 million. We expect non-GAAP net income of at least 20% of revenue for fiscal year 2027.
"Demand for our FOX™ wafer-level burn-in (WLBI) solutions remains strong. Our lead AI processor WLBI production customer continues to expand capacity, supported by the $22 million follow-on order announced in August 2026. We have also made significant progress with a major supplier of AI accelerators, CPUs, and network processors that successfully completed a benchmark evaluation last quarter. This customer has decided to purchase a fully configured FOX-XP WLBI test cell for installation at one of its key Outsourced Semiconductor Assembly and Test (OSAT) partners in Taiwan, where the system will be evaluated in a high-volume production environment using the same device that was successfully tested in last quarter's benchmark. Installation is planned for early calendar 2027, with a decision regarding high-volume production anticipated within several months following installation and validation. We believe this customer represents one of the largest potential burn-in system opportunities Aehr has ever pursued, with significant potential across multiple product lines and manufacturing locations.
"Our Sonoma high-power package-level burn-in (PLBI) business is also expanding rapidly. We are currently shipping and installing more than a dozen systems per month to support our lead hyperscale customer's production ramp for its first AI processor. The same customer's second AI processor has now successfully completed qualification on Sonoma, and we have received follow-on orders to support initial production sampling and an anticipated production ramp in calendar 2027. Importantly, the customer forecasts that this second processor will ultimately reach higher production volumes than its first. We are also advancing evaluations with additional AI processor suppliers and hyperscale customers, creating opportunities for new production programs.
"Another important development is the significant diversification of our customer base. Historically, we had only a handful of customers with the potential to generate significant production orders. Today, we see that potential across more than a dozen customers spanning AI processors, silicon photonics, silicon carbide, gallium nitride, and other applications.
"With existing customers expanding production, new AI processor programs advancing toward high-volume production, and an increasingly diversified pipeline of opportunities, we believe Aehr is exceptionally well positioned to capitalize on the growing need for advanced semiconductor test and burn-in solutions over the next several years."
Financial Guidance
For fiscal 2027 ending June 25, 2027, Aehr now expects:
- Revenue of $150 million, compared with its previous guidance range of $130 million to $150 million.
- Non-GAAP net income of at least 20% of revenue.
The updated revenue outlook represents 200% growth over fiscal 2026.
The increased outlook reflects Aehr's strong first quarter performance, substantial backlog, increasing visibility into existing customer production programs, and anticipated production and delivery schedules. Aehr continues to pursue additional opportunities with existing and prospective customers that could support additional growth in fiscal 2027 and beyond.
Management Conference Call and Webcast:
Aehr Test Systems will host a conference call and webcast today at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss its first quarter fiscal 2027 financial results. To access the live call, dial +1 888-506-0062 (US and Canada) or +1 973-528-0011 (International) and give the participant passcode 953740. In addition, a live and archived webcast of the conference call will be available over the Internet at www.aehr.com in the Investor Relations section and may also be accessed by clicking here. A phone replay of the call will be available approximately two hours following the end of the live call and will remain available for one week. To access the call replay, dial +1 877-481-4010 (US and Canada) or +1 919-882-2331 (International) and enter replay passcode 54635.
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning in, and stabilizing semiconductor devices in wafer-level, singulated die, and package-level form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including advanced AI processors, silicon photonics, data and telecommunications infrastructure, electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, and solid-state memory and storage are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr's products and solutions. Aehr has developed and introduced several innovative products including the FOX-P™ families of test and burn-in systems and the FOX WaferPak™Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full-wafer contact and singulated die/module test and burn-in systems that can test, burn in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full-wafer contactor capable of testing wafers up to 300mm, enabling IC manufacturers to perform test, burn-in, and stabilization of full wafers on FOX-P systems. The FOX DiePak Carrier allows testing, burn-in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. Through its acquisition of Incal Technology, Inc., Aehr added a line of high-power package-level reliability/burn-in test solutions for AI semiconductor manufacturers, including its ultra-high-power Sonoma family of test solutions for AI accelerators, GPUs, and high-performance computing (HPC) processors, which position Aehr within the rapidly growing AI market as a turnkey provider of reliability and test solutions that span from engineering to high-volume production. For more information, please visit Aehr Test Systems' website at www.aehr.com.
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or Aehr's future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "forecasts." "predicts," "potential," or "continue," or the negative of these words or other similar terms or expressions that concern Aehr's expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, statements regarding future bookings, backlog, benchmark evaluations and product development from Aehr's new and existing customers; future applications and orders for AI processors, test solutions for AI semiconductor manufacturers and the Sonoma system; customer forecasts, and production ramps; revenue and revenue growth forecasted; financial performance and bookings forecasted; financial guidance for the fiscal year 2027, including revenue; expectations regarding current and future partnerships; expectations regarding industry demand and emerging technologies as a whole and smaller segments within it; and the ability for Aehr to successfully enter new markets. These forward-looking statements are based on management's current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including, among others, the non-binding nature of customer forecasts; the possibility that orders are canceled, rescheduled, or delayed; macroeconomic, trade, tariff, and geopolitical conditions, including those affecting Taiwan and Southeast Asia; and conditions in the semiconductor, AI, silicon carbide, GaN, and memory markets. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr's most recent Annual Report on Form 10-K, and subsequent Quarterly Reports on Form 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release, except as required by law.
Contacts:
| Aehr Test Systems Chris Siu Chief Financial Officer [email protected] | PondelWilkinson Todd Kehrli Investor Contact [email protected] |
-Financial Tables to Follow-
AEHR TEST SYSTEMS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
| Three Months Ended | One Month Ended | |||||||||||
| September 25, | May 29, | August 29, | June 26, | |||||||||
(In thousands, except per share data) | 2026 | 2026 | 2025 | 2026 | ||||||||
Revenue | $ | 33,007 | $ | 18,835 | $ | 10,969 | $ | 638 | ||||
Cost of revenue | 17,344 | 10,816 | 7,250 | 1,650 | ||||||||
Gross profit (loss) | 15,663 | 8,019 | 3,719 | (1,012 | ) | |||||||
Operating expenses: | ||||||||||||
Research and development | 4,143 | 3,645 | 2,849 | 1,164 | ||||||||
Selling, general and administrative | 5,473 | 5,580 | 4,717 | 1,819 | ||||||||
Restructuring charges | - | - | 219 | - | ||||||||
Total operating expenses | 9,616 | 9,225 | 7,785 | 2,983 | ||||||||
Income (loss) from operations | 6,047 | (1,206 | ) | (4,066 | ) | (3,995 | ) | |||||
Interest income, net | 899 | 748 | 179 | 301 | ||||||||
Other income (expense), net | (19 | ) | 3 | 1,051 | 21 | |||||||
Income (loss) before income tax expense (benefit) | 6,927 | (455 | ) | (2,836 | ) | (3,673 | ) | |||||
Income tax benefit | (254 | ) | (1,846 | ) | (752 | ) | (930 | ) | ||||
Net income (loss) | $ | 7,181 | $ | 1,391 | $ | (2,084 | ) | $ | (2,743 | ) | ||
Net income (loss) per share: | ||||||||||||
Basic | $ | 0.22 | $ | 0.04 | $ | (0.07 | ) | $ | (0.08 | ) | ||
Diluted | $ | 0.21 | $ | 0.04 | $ | (0.07 | ) | $ | (0.08 | ) | ||
Shares used in per share calculations: | ||||||||||||
Basic | 32,619 | 31,881 | 29,923 | 32,485 | ||||||||
Diluted | 33,520 | 33,170 | 29,923 | 32,485 | ||||||||
Effective fiscal 2027, the Company changed its fiscal year-end from the Friday nearest May 31 to the Friday nearest June 30. The three months ended September 25, 2026 reflect the period from June 27, 2026 through September 25, 2026. The one month ended June 26, 2026 represents the transition period (May 30, 2026 to June 26, 2026) between the end of fiscal 2026 and the start of fiscal 2027. Financial information for the three months ended September 26, 2025 is not presented because the three months ended August 29, 2025 provide a meaningful comparison to the three months ended September 25, 2026.
AEHR TEST SYSTEMS
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(Unaudited)
| Three Months Ended | One Month Ended | |||||||||||
| September 25, | May 29, | August 29, | June 26, | |||||||||
(In thousands, except per share data) | 2026 | 2026 | 2025 | 2026 | ||||||||
Reconciliation of GAAP to non-GAAP gross profit (loss) | ||||||||||||
GAAP gross profit (loss) | $ | 15,663 | $ | 8,019 | $ | 3,719 | $ | (1,012 | ) | |||
Special items: | ||||||||||||
a) Stock-based compensation expense | 171 | 216 | 159 | 36 | ||||||||
b) Acquisition-related adjustments | 190 | 191 | 237 | 63 | ||||||||
Non-GAAP gross profit (loss) | $ | 16,024 | $ | 8,426 | $ | 4,115 | $ | (913 | ) | |||
Reconciliation of GAAP to non-GAAP operating expenses | ||||||||||||
GAAP operating expenses | $ | 9,616 | $ | 9,225 | $ | 7,785 | $ | 2,983 | ||||
Special items: | ||||||||||||
a) Stock-based compensation expense | (1,709 | ) | (1,649 | ) | (1,512 | ) | (412 | ) | ||||
b) Acquisition-related adjustments | (106 | ) | (105 | ) | (105 | ) | (35 | ) | ||||
c) Restructuring charges | - | - | (219 | ) | - | |||||||
Non-GAAP operating expenses | $ | 7,801 | $ | 7,471 | $ | 5,949 | $ | 2,536 | ||||
Reconciliation of GAAP to non-GAAP income (loss) from operations | ||||||||||||
GAAP income (loss) from operations | $ | 6,047 | $ | (1,206 | ) | $ | (4,066 | ) | $ | (3,995 | ) | |
Special items: | ||||||||||||
a) Stock-based compensation expense | 1,880 | 1,865 | 1,671 | 448 | ||||||||
b) Acquisition-related adjustments | 296 | 296 | 342 | 98 | ||||||||
c) Restructuring charges | - | - | 219 | - | ||||||||
Non-GAAP income (loss) from operations | $ | 8,223 | $ | 955 | $ | (1,834 | ) | $ | (3,449 | ) | ||
Reconciliation of GAAP to non-GAAP income (loss) before income tax benefit | ||||||||||||
GAAP income (loss) before income tax benefit | $ | 6,927 | $ | (455 | ) | $ | (2,836 | ) | $ | (3,673 | ) | |
Special items: | ||||||||||||
a) Stock-based compensation expense | 1,880 | 1,865 | 1,671 | 448 | ||||||||
b) Acquisition-related adjustments | 296 | 296 | 365 | 98 | ||||||||
c) Restructuring charges | - | - | 219 | - | ||||||||
Non-GAAP income (loss) before income tax benefit | $ | 9,103 | $ | 1,706 | $ | (581 | ) | $ | (3,127 | ) | ||
Reconciliation of GAAP to non-GAAP net income (loss) | ||||||||||||
GAAP net income (loss) | $ | 7,181 | $ | 1,391 | $ | (2,084 | ) | $ | (2,743 | ) | ||
Special items: | ||||||||||||
a) Stock-based compensation expense | 1,880 | 1,865 | 1,671 | 448 | ||||||||
b) Acquisition-related adjustments | 296 | 296 | 365 | 98 | ||||||||
c) Restructuring charges | - | - | 219 | - | ||||||||
Non-GAAP net income (loss) | $ | 9,357 | $ | 3,552 | $ | 171 | $ | (2,197 | ) | |||
Reconciliation of GAAP to non-GAAP income (loss) per diluted share | ||||||||||||
GAAP income (loss) per diluted share | $ | 0.21 | $ | 0.04 | $ | (0.07 | ) | $ | (0.08 | ) | ||
Special items: | ||||||||||||
a) Stock-based compensation expense | 0.06 | 0.06 | 0.06 | 0.01 | ||||||||
b) Acquisition-related adjustments | 0.01 | 0.01 | 0.01 | 0.00 | ||||||||
c) Restructuring charges | - | - | 0.01 | - | ||||||||
Non-GAAP income (loss) per diluted share | $ | 0.28 | $ | 0.11 | $ | 0.01 | $ | (0.07 | ) | |||
a) Represents compensation expense for equity awards granted to employees and directors.
b) Represents amortization of acquired intangible assets and accretion expense of escrow payable.
c) Represents employee termination benefits.
Non-GAAP measures should not be considered a replacement for GAAP results. The non-GAAP measures indicated above are financial measures the Company uses to evaluate the underlying results and operating performance of the business. The limitation of these measures are that they exclude items that impact the Company's current period GAAP measures. This limitation is best addressed by using these measures in combination with the most directly comparable GAAP financial measures. These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies.
We believe these measures enhance investors' ability to review the Company's business from the same perspective as the Company's management and facilitate comparisons of this period's results with prior periods.
AEHR TEST SYSTEMS
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
| September 25, | June 26, | May 29, | ||||
(In thousands, except par value) | 2026 | 2026 | 2026 | |||
ASSETS | ||||||
Current assets: | ||||||
Cash and cash equivalents | $ | 104,902 | $ | 112,308 | $ | 116,358 |
Accounts receivable | 26,630 | 15,946 | 17,473 | |||
Inventories | 53,120 | 44,410 | 41,354 | |||
Prepaid expenses and other current assets | 11,225 | 9,745 | 9,263 | |||
Total current assets | 195,877 | 182,409 | 184,448 | |||
Property and equipment, net | 8,820 | 8,814 | 8,940 | |||
Goodwill | 10,719 | 10,719 | 10,719 | |||
Intangible assets, net | 9,157 | 9,453 | 9,552 | |||
Deferred tax assets, net | 25,120 | 24,766 | 23,829 | |||
Operating lease right-of-use assets, net | 8,812 | 8,838 | 8,901 | |||
Other non-current assets | 277 | 306 | 305 | |||
Total assets | $ | 258,782 | $ | 245,305 | $ | 246,694 |
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||
Current liabilities: | ||||||
Accounts payable | $ | 12,504 | $ | 6,353 | $ | 6,754 |
Accrued expenses and other current liabilities | 6,295 | 5,214 | 5,283 | |||
Operating lease liabilities, short-term | 653 | 592 | 626 | |||
Deferred revenue, short-term | 7,944 | 6,698 | 5,192 | |||
Total current liabilities | 27,396 | 18,857 | 17,855 | |||
Operating lease liabilities, long-term | 9,151 | 9,202 | 9,256 | |||
Deferred revenue, long-term | 86 | 56 | 34 | |||
Other long-term liabilities | 37 | 38 | 38 | |||
Total liabilities | 36,670 | 28,153 | 27,183 | |||
Shareholders' equity: | ||||||
Preferred stock, $0.01 par value: Authorized: 10,000 shares; | ||||||
Issued and outstanding: none | - | - | - | |||
Common stock, $0.01 par value: Authorized: 75,000 shares; | ||||||
Issued and outstanding: 32,663 shares, 32,491 shares and 32,480 shares at September 25, 2026, June 26, 2026, and May 29, 2026, respectively | 327 | 325 | 325 | |||
Additional paid-in capital | 247,669 | 249,888 | 249,477 | |||
Accumulated other comprehensive loss | (136 | ) | (132 | ) | (105 | ) |
Accumulated deficit | (25,748 | ) | (32,929 | ) | (30,186 | ) |
Total shareholders' equity | 222,112 | 217,152 | 219,511 | |||
Total liabilities and shareholders' equity | $ | 258,782 | $ | 245,305 | $ | 246,694 |
AEHR TEST SYSTEMS
CONDENSED CONSOLIDATED SATEMENTS OF CASH FLOWS
(Unaudited)
| Three Months Ended | One Month Ended | |||||||
| September 25, | August 29, | June 26, | ||||||
(In thousands) | 2026 | 2025 | 2026 | |||||
Cash flows from operating activities: | ||||||||
Net income (loss) | $ | 7,181 | $ | (2,084 | ) | $ | (2,743 | ) |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||
Stock-based compensation expense | 1,880 | 1,671 | 448 | |||||
Depreciation and amortization | 707 | 743 | 228 | |||||
Deferred income taxes | (354 | ) | (761 | ) | (937 | ) | ||
Amortization of operating lease right-of-use assets | 200 | 179 | 63 | |||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | (10,686 | ) | 1,140 | 1,492 | ||||
Inventories | (9,037 | ) | 218 | (3,035 | ) | |||
Prepaid expenses and other current assets | (1,367 | ) | 1,576 | (484 | ) | |||
Accounts payable | 6,230 | (2,401 | ) | (219 | ) | |||
Accrued expenses | 998 | 505 | (76 | ) | ||||
Deferred revenue | 1,275 | (863 | ) | 1,529 | ||||
Operating lease liabilities | (164 | ) | (215 | ) | (88 | ) | ||
Income taxes payable | 83 | 10 | 10 | |||||
Net cash used in operating activities | (3,054 | ) | (282 | ) | (3,812 | ) | ||
Cash flows from investing activities: | ||||||||
Purchases of property and equipment | (49 | ) | (1,391 | ) | (4 | ) | ||
Net cash used in investing activities | (49 | ) | (1,391 | ) | (4 | ) | ||
Cash flows from financing activities: | ||||||||
Proceeds from issuance of common stock under employee plans | 337 | 170 | 13 | |||||
Shares repurchased for tax withholdings on vesting of restricted stock units | (4,474 | ) | (328 | ) | (71 | ) | ||
Payments for common stock issuance costs related to the public offering | (161 | ) | - | (176 | ) | |||
Net cash used in financing activities | (4,298 | ) | (158 | ) | (234 | ) | ||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (5 | ) | 9 | - | ||||
Net decrease in cash, cash equivalents and restricted cash | (7,406 | ) | (1,822 | ) | (4,050 | ) | ||
Cash, cash equivalents and restricted cash, beginning of period(1) | 112,458 | 26,480 | 116,508 | |||||
Cash, cash equivalents and restricted cash, end of period (1) | $ | 105,052 | $ | 24,658 | $ | 112,458 | ||
Supplemental disclosure of non-cash flow information: | ||||||||
Net transfer of equipment between inventory and property and equipment | $ | 367 | $ | - | $ | - | ||
Right-of-use assets obtained in exchange for operating leases liabilities | $ | 174 | $ | - | $ | - | ||
(1) Includes restricted cash within prepaid expenses and other current assets and other non-current assets.
SOURCE: Aehr Test Systems
View the original press release on ACCESS Newswire
X.Eom--SG
